Investors / United States / Vensana Capital
Vensana Capital
Venture capital · Minneapolis, MN, United States · North America
Vensana Capital is a venture capital and growth equity investment firm focused on medical technology. It invests in development and commercial stage companies across the medtech sector.
Invests inHealthcare & Biotech
In its own wordsmedtechmedical devicesdiagnosticsdigital healthdrug deliverylife science tools
Your fit with Vensana Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVensana Capital lists 6 checked portfolio companies on its own site and is named in 6 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (86%) and AI & Machine Learning (14%). 100% of its companies are based in United States. It invests most often alongside Gilde Healthcare, Boutique Venture Partners and Casdin Capital.
Counts come from funding rounds that name Vensana Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 60% |
| Series B | 20% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 1 |
| '26 | 3 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 8th | 6 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 94th | 86% in its largest sector |
| Reach | 19th | 1 country |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Gilde Healthcare | 2 |
| Boutique Venture Partners | 1 |
| Casdin Capital | 1 |
| Creative Destruction Lab | 1 |
| Eight Capital | 1 |
| K2 HealthVentures | 1 |
| Layout Ventures | 1 |
| Longitude Capital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers6100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 86% | 15% |
| AI & Machine Learning | 14% | 18% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Gilde Healthcare
Compare Vensana Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Vensana Capital| Date | Company | Stage |
|---|---|---|
| 21 Jul 2026 | Series A Led | |
| 9 Jan 2026 | Series A | |
| 8 Jan 2026 | Series B | |
| 19 Nov 2025 | Round | |
| 18 Aug 2025 | Series A Led | |
| 2 Jun 2025 | Series C+ |
Round details for Vensana Capital
Amounts, full round histories and every co-investor in Vensana Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
6 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Apella provides ambient AI for operating rooms to optimize capacity, streamline coordination, and improve patient care. | Healthcare & BiotechAI & Machine Learning | Jan 2026Series B | Funding round | |
| Luna Diabetes develops automated insulin delivery systems for insulin pen users to manage nighttime diabetes | Healthcare & Biotech | Aug 2025Series A | Funding round | |
| Okami Medical develops and sells medical devices for vascular occlusion and infusion of diagnostic and therapeutic agents. | Healthcare & Biotech | Nov 2025Round | Funding round | |
| SpyGlass Pharma develops a system for sustained drug delivery to manage chronic eye disease | Healthcare & Biotech | Jun 2025Series C+ | Funding round | |
| Tybr Health develops and sells a gel system for improving post-operative tendon mobility | Healthcare & Biotech | Jul 2026Series A | Funding round | |
| Ventaris develops investigational medical devices | Healthcare & Biotech | Jan 2026Series A | Funding round |
About this data
site last read 5 Nov 2026- Site
- vensanacap.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 2 Jun 2025
- Companies checked
- 6
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Vensana Capital's profile as data
Pull Vensana Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vensanacap.com
# also
GET /v1/firms/vensanacap.com/portfolio
GET /v1/firms/vensanacap.com/coinvestors
GET /v1/firms/vensanacap.com/news